The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

Last Updated On November 29, 2025

Get Up to 20% OFF

News

Joe Wicks looks back: ‘When I look at that picture, I think about the care and love a kid needs’

After three years of long-distance, my partner and I aren’t sure if we should stay together

Cycling is changing at speed – but is Britain keeping pace?

‘I’m going to scream!’: how to survive (and maybe even enjoy) your family Christmas

‘A potential treasure trove’: World Health Organization to explore benefits of traditional medicines

I threw a potato. Mum brandished a knife … would whole-family therapy save our Christmas?

2025-11-28 – Press Releases – www.prnewswire.com

CHENGDU, China, Nov. 28, 2025 /PRNewswire/ — Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990)’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic urothelial carcinoma (UC) patients has…

Read the full article here.

Get Up to 20% OFF

Related Feeds

Dr.AI Empowers Smart Hospitals with Pre-Consults and Real-Time Transcriptions, Winning the COMPUTEX Digital Healthcare Award

NEC Drives the Future of Smart Living By Elevating Health, Cybersecurity, and Disaster Resilience at Thailand Smart City Expo 2025

My identity had been stolen but Three failed to respond

The Big Idea: looking for a better life? Follow your nose

A moment that changed me: I was told my home was haunted – and it made me a tidier, happier person

7 children die of Diphtheria in Rajasthan: Know its common symptoms, causes and treatment

Global study targets dengue as disease threatens nearly half the world’s population

Cumulative social advantage: is this the secret to a long, happy, healthy life?

Illuccix China Phase 3 Study Completes Enrolment

Merz Aesthetics® Tops Best Workplaces in Asia 2025 List by Great Place To Work®

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

Running on empty: why are so many marathon runners so miserable?

NYSE Content Advisory: Pre-Market Update + Embraer celebrates 25th listing anniversary

Five USANA Country/Region Markets Recognized for Product Excellence by Euromonitor International

Ram Kapoor lost 55 kg with cardio, strength training, and intermittent fasting

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

COMPANY

Mon-Fri 10 am to 7 pm.

Warehouse: (No Walk-In)

Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)

Qxpress, 30 Tuas West Rd, level 5, S (638386)

Wellness

Unlocking the Secrets to a More Active Lifestyle After 40

Wellness

25 Min Full Body Resistance Band Workout for Women & Men – Elastic Exercise Band Workouts Training

Wellness

Guided Sleep Meditation Let Go of Anxiety, Foster Wellness While You Sleep

Beauty

Resveratrol: The Skin Tightening Secret

Beauty

Every Skin Type’s Best Friend: The Comprehensive Benefits of Niacinamide Serum

Beauty

Beyond Sunscreen: The New Age of Sun Protection Is Here

All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.